Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.42 USD | -2.05% | +5.43% | -24.23% |
05-15 | Legend Expects to Log Profit in 2026 | MT |
05-14 | HC Wainwright Adjusts Price Target on Legend Biotech to $86 From $87, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.23% | 8.45B | |
+8.59% | 114B | |
+10.80% | 104B | |
-12.90% | 22.41B | |
-1.19% | 22.28B | |
-5.24% | 19.07B | |
-38.29% | 18B | |
-5.05% | 17.89B | |
+7.57% | 14.28B | |
+35.84% | 12.55B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- RBC Capital Lifts Legend Biotech Price Target to $74 From $73, Maintains Outperform Rating